TrialBritish journal of clinical pharmacology2021

Safety, pharmacokinetics and pharmacodynamics of TAK-418, a novel inhibitor of the epigenetic modulator lysine-specific demethylase 1A.

Wei Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.